Put a little money away, let it work for you. The name of the company is Cannabis Science Inc. (Public, OTC:CBIS).
“We are very pleased to be on board with Cannabis Science for the long run,” Don Shaxon from Catalyst Xchange Corp. indicated. “We thoroughly understand the multi-billion dollar pharmaceutical market that the company seeks to enter. Fortunately, Cannabis Science understands it as well and is positioning itself with cannabis-based products, which some hail as the next class of pharmaceutical blockbusters. Cannabis Science has hired the right people, Ray Carr, R.Ph., and Mary Ruwart, Ph.D., to head up the efforts to get the company’s unique cannabis-based pharmaceuticals through the FDA approval process. We are focused on immediately assisting this effort by raising share value and investment capital for the company.” Here is a link for this article http://www.businesswire.com/news/google/20090702005580/en
Cannabis Science is currently trading at $00.185 a share. I am currently buying $100.00 worth, I am looking at a the long haul at least a couple of years. Depending on the news we get from California we may see that stock raise. We all know the saying if California goes so do the Nation.
No comments:
Post a Comment